218 related articles for article (PubMed ID: 20830810)
1. Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy.
Mishra A; Newman EA
Glia; 2010 Dec; 58(16):1996-2004. PubMed ID: 20830810
[TBL] [Abstract][Full Text] [Related]
2. Aminoguanidine reverses the loss of functional hyperemia in a rat model of diabetic retinopathy.
Mishra A; Newman EA
Front Neuroenergetics; 2011; 3():10. PubMed ID: 22291637
[TBL] [Abstract][Full Text] [Related]
3. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes.
Li J; Wang P; Ying J; Chen Z; Yu S
Cell Physiol Biochem; 2016; 39(3):1196-208. PubMed ID: 27595397
[TBL] [Abstract][Full Text] [Related]
4. Upregulated endothelin system in diabetic vascular dysfunction and early retinopathy is reversed by CPU0213 and total triterpene acids from Fructus Corni.
Su W; Dai DZ; Liu HR; Na T; Dai Y
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1228-33. PubMed ID: 17973859
[TBL] [Abstract][Full Text] [Related]
5. Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats.
Du Y; Sarthy VP; Kern TS
Am J Physiol Regul Integr Comp Physiol; 2004 Oct; 287(4):R735-41. PubMed ID: 15371279
[TBL] [Abstract][Full Text] [Related]
6. Purinergic receptor activation inhibits osmotic glial cell swelling in the diabetic rat retina.
Wurm A; Iandiev I; Hollborn M; Wiedemann P; Reichenbach A; Zimmermann H; Bringmann A; Pannicke T
Exp Eye Res; 2008 Oct; 87(4):385-93. PubMed ID: 18687327
[TBL] [Abstract][Full Text] [Related]
7. Contribution of nitric oxide synthase isoforms to cholinergic vasodilation in murine retinal arterioles.
Gericke A; Goloborodko E; Sniatecki JJ; Steege A; Wojnowski L; Pfeiffer N
Exp Eye Res; 2013 Apr; 109():60-6. PubMed ID: 23434456
[TBL] [Abstract][Full Text] [Related]
8. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes.
Zheng L; Du Y; Miller C; Gubitosi-Klug RA; Kern TS; Ball S; Berkowitz BA
Diabetologia; 2007 Sep; 50(9):1987-1996. PubMed ID: 17583794
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability.
Carmo A; Cunha-Vaz JG; Carvalho AP; Lopes MC
Nitric Oxide; 2000 Dec; 4(6):590-6. PubMed ID: 11139367
[TBL] [Abstract][Full Text] [Related]
10. Nitrosative Stress in the Rat Retina at the Onset of Streptozotocin-Induced Diabetes.
Hernández-Ramírez E; Sánchez-Chávez G; Estrella-Salazar LA; Salceda R
Cell Physiol Biochem; 2017; 42(6):2353-2363. PubMed ID: 28848155
[TBL] [Abstract][Full Text] [Related]
11. Retinoprotective effect of agmatine in streptozotocin-induced diabetic rat model: avenues for vascular and neuronal protection : Agmatine in diabetic retinopathy.
Abo El Gheit RE; Soliman NA; Badawi GA; Madi NM; El-Saka MH; Badr SM; Emam MN
J Physiol Biochem; 2021 May; 77(2):305-320. PubMed ID: 33635523
[TBL] [Abstract][Full Text] [Related]
12. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine.
Du Y; Smith MA; Miller CM; Kern TS
J Neurochem; 2002 Mar; 80(5):771-9. PubMed ID: 11948240
[TBL] [Abstract][Full Text] [Related]
13. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
14. The role of the sodium hydrogen exchanger-1 in mediating diabetes-induced changes in the retina.
Cukiernik M; Hileeto D; Downey D; Evans T; Khan ZA; Karmazyn M; Chakrabarti S
Diabetes Metab Res Rev; 2004; 20(1):61-71. PubMed ID: 14737747
[TBL] [Abstract][Full Text] [Related]
15. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570
[TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy.
Sennlaub F; Courtois Y; Goureau O
J Neurosci; 2002 May; 22(10):3987-93. PubMed ID: 12019318
[TBL] [Abstract][Full Text] [Related]
17. S-nitrosoglutathione inhibits inducible nitric oxide synthase upregulation by redox posttranslational modification in experimental diabetic retinopathy.
Rosales MA; Silva KC; Duarte DA; de Oliveira MG; de Souza GF; Catharino RR; Ferreira MS; Lopes de Faria JB; Lopes de Faria JM
Invest Ophthalmol Vis Sci; 2014 May; 55(5):2921-32. PubMed ID: 24699383
[TBL] [Abstract][Full Text] [Related]
18. Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.
Roufail E; Soulis T; Boel E; Cooper ME; Rees S
Diabetologia; 1998 Dec; 41(12):1419-25. PubMed ID: 9867208
[TBL] [Abstract][Full Text] [Related]
19. Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy.
McVicar CM; Hamilton R; Colhoun LM; Gardiner TA; Brines M; Cerami A; Stitt AW
Diabetes; 2011 Nov; 60(11):2995-3005. PubMed ID: 21911748
[TBL] [Abstract][Full Text] [Related]
20. High-salt loading exacerbates increased retinal content of aquaporins AQP1 and AQP4 in rats with diabetic retinopathy.
Qin Y; Xu G; Fan J; Witt RE; Da C
Exp Eye Res; 2009 Nov; 89(5):741-7. PubMed ID: 19596320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
